<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01916148</url>
  </required_header>
  <id_info>
    <org_study_id>12-009528</org_study_id>
    <nct_id>NCT01916148</nct_id>
  </id_info>
  <brief_title>18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia</brief_title>
  <official_title>Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <brief_summary>
    <textblock>
      This purpose of this study is to determine the ability of an
      18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET scan to detect a focal lesion of
      hyperinsulinism and determine the location in patients with congenital hyperinsulinism,
      Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.
    </textblock>
  </brief_summary>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <condition>Congenital Hyperinsulinism</condition>
  <condition>Beckwith-Wiedemann Syndrome</condition>
  <condition>Insulinoma</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>18F-DOPA</intervention_name>
    <description>18F-DOPA is a PET scan radiotracer.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects of any age with hyperinsulinemic hypoglycemia, diagnosed by a fasting test
             and/or response to glucagon stimulation.

          -  Subjects who are eligible for pancreatic surgery regardless of prior pancreatic
             surgery

        Exclusion Criteria:

          -  Pregnant or lactating females

          -  Any other major illness or condition that in the investigator's judgment will
             substantially increase the risk associated with the subject's participation in this
             study

          -  Subjects who are not a candidate for pancreatic surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Lisa States, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susan Becker, RN, BSN, CCRC</last_name>
    <phone>267-426-0269</phone>
    <email>Beckers@email.chop.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lisa States, MD</last_name>
    <phone>267-425-7146</phone>
    <email>States@email.chop.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <investigator>
      <last_name>Lisa States, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2013</study_first_submitted>
  <study_first_submitted_qc>August 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2013</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Philadelphia</investigator_affiliation>
    <investigator_full_name>Lisa States</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hypoglycemia</keyword>
  <keyword>Hyperinsulinism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Hyperinsulinism</mesh_term>
    <mesh_term>Insulinoma</mesh_term>
    <mesh_term>Congenital Hyperinsulinism</mesh_term>
    <mesh_term>Beckwith-Wiedemann Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

